𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nitric oxide synthase gene therapy enhances the toxicity of cisplatin in cancer cells

✍ Scribed by Catherine Adams; Helen O. McCarthy; Jonathan A. Coulter; Jenny Worthington; Claire Murphy; Tracy Robson; David G. Hirst

Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
206 KB
Volume
11
Category
Article
ISSN
1099-498X

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

Nitric oxide (NO·) derived from donor drugs has been shown to be an effective chemosensitizer in vitro. We investigated the combination of inducible nitric oxide synthase (iNOS) gene transfer, driven by a strong constitutive promoter (cytomegalovirus; CMV) with the DNA cross‐linking agent cisplatin in mouse and human tumour cell lines.

Methods

Proof of principal experiments were performed in the radiation‐induced fibrosarcoma‐1 (RIF‐1) murine cell line. Cells were transfected with constitutively expressed CMV/iNOS plasmid DNA using a cationic lipid vector, before exposure to cisplatin. In vivo efficacy was determined in an intradermal RIF‐1 tumour model, with intraperitoneal administration of cisplatin. Additionally, treatment potential was investigated in various human tumour cell lines including human prostate (DU145 and PC3) and human colon (HT29 and HCT116) cancer cell lines. Experimental endpoints were established using western blot, Greiss test, clonogenic assay and tumour growth delay.

Results

Transfection of RIF‐1 tumour cells in vitro with the CMV/iNOS significantly enhanced the cytotoxicity of cisplatin (0.2–1.0 µM). In vivo transfer of CMV/iNOS by direct injection into established RIF‐1 tumours caused a significant (p = 0.0027) delay in tumour growth. CMV/iNOS gene transfer in vitro resulted in the strong expression of iNOS DNA in all cell lines, and significantly increased levels of NO· in all cell lines except HCT116.

Conclusions

Significant chemosensitization of cisplatin cytotoxicity was observed in the presence of NO· derived from the overexpression iNOS. We conclude that p53 status of the various cell lines was unlikely to be responsible for cisplatin‐induced apoptosis. Copyright © 2008 John Wiley & Sons, Ltd.

📜 SIMILAR VOLUMES

Gene therapy of rat medullary thyroid ca
Gene therapy of rat medullary thyroid cancer by naked nitric oxide synthase II DNA injection
✍ M. N. Soler; P. Bobé; K. Benihoud; G. Lemaire; B. A. Roos; S. Lausson 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB

## Background: Nitric oxide (no), produced by no synthase ii (nos ii), is the main mediator of the tumoricidal action of activated macrophages. in the present study we examined the potential of the nos ii gene as a suicide gene for medullary thyroid cancer (mtc) therapy. ## Methods: We orthotopic

Transcriptional regulation of inducible
Transcriptional regulation of inducible nitric oxide synthase gene therapy: targeting early stage and advanced prostate cancer
✍ Jonathan A. Coulter; Natalie L. Page; Jenny Worthington; Tracy Robson; David G. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

## Abstract ## Background Using the tumour type specific human osteocalcin (hOC) promoter, we have previously reported strong promoter activation in hormone independent prostate cancer cells __in vitro.__ In the present study, we present a comparative study of the tissue specific promoter prostate

Evidence for the involvement of nitric o
Evidence for the involvement of nitric oxide in cisplatin-induced toxicity in rats
✍ R. C. Srivastava; A. Farookh; Nihal Ahmad; Minakshi Misra; S. K. Hasan; M. M. Hu 📂 Article 📅 1996 🏛 Springer Netherlands 🌐 English ⚖ 266 KB

Cisplatin treatment of rats results into a significant increase in the activity of Ca(2+)-independent nitric oxide synthase (NOS) in kidneys and liver. Significant enhancement of lipid peroxidation in gastric mucosa, kidneys and liver was also observed. The administration of NG-nitro-L-arginine meth

Molecular cloning and expression of nitr
Molecular cloning and expression of nitric oxide synthase gene in chick embryonic muscle cells
✍ Dae Kun Kim; Eun Kyung Hong; Kun Ho Lee; Jae Il Kim; Woo Keun Song 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 2 views

The chick skeletal muscle nitric oxide synthase (NOS) gene was cloned in order to further de®ne the involvement of NOS in the dierentiation of skeletal muscle cells. The respective cDNA had an open reading frame of 1136 amino acid residues, predicting a protein of 129,709.85 Da, and recognition site

An intron 4 VNTR polymorphism of the end
An intron 4 VNTR polymorphism of the endothelial nitric oxide synthase gene is associated with early-onset colorectal cancer
✍ Chih-Ching Yeh; Regina M. Santella; Ling-Ling Hsieh; Fung-Chang Sung; Reiping Ta 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 103 KB

## Abstract Endothelial‐derived nitric oxide, which is produced by endothelial nitric oxide synthase (eNOS), may play an important role in colorectal carcinogenesis. However, the putative contribution of common __eNOS__ genetic polymorphisms to colorectal cancer risk remains unknown. We genotyped 3

Neutrophils enhance expression of induci
Neutrophils enhance expression of inducible nitric oxide synthase in human normal but not cystic fibrosis bronchial epithelial cells
✍ Meng, Qing-Hai; Polak, Julia M.; Edgar, Alasdair J.; Chacon, Matilde R.; Evans, 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 204 KB 👁 2 views

The bronchial epithelium in cystic ®brosis (CF) expresses very low levels of the inducible form of nitric oxide synthase (iNOS). The product of iNOS, nitric oxide (NO), mediates anti-microbial effects and can reduce neutrophil sequestration in the lung. Heavy neutrophilic in®ltration of the pulmonar